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Abstract 
Phosphatidylinositol 5-phosphate 4-kinases (PI5P4Ks) are enigmatic lipid kinases 
whose physiological functions are incompletely understood, not least because genetic 
deletion and cell transfection have led to contradictory data. Here we used the genetic 
tractability of DT40 cells to create cell lines in which endogenous PI5P4Kα was 
removed either stably by genetic deletion, or transiently (within one hour) by tagging 
the endogenous protein genomically with the auxin degron. In both cases removal 
impacted upon Akt phosphorylation, and by leaving one PI5P4Kα allele present but 
mutating it to be kinase-dead or to have PI4P 5-kinase activity we show that all the 
effects on Akt phosphorylation were dependent upon the ability of PI5P4Kα to 
synthesise PI(4,5)P2 rather than to remove PI5P. Whilst stable removal of PI5P4Kα 
resulted in a pronounced decrease in Akt phosphorylation at Thr308 and Ser473, due 
in part to reduced plasma membrane PIP3, its acute removal led to an increase in Akt 
phosphorylation only at Ser473. This invokes activation primarily of mTORC2, 
which was confirmed by increased phosphorylation of other mTORC2 substrates. 
These findings establish PI5P4Kα as a kinase that synthesizes a physiologically 
relevant pool of PI(4,5)P2 and as a novel regulator of mTORC2.  They also show a 
phenomenon similar to the ‘butterfly effect’ described for PI 3-kinase Iα (Hart JR et al 
PNAS 112 1131-1136; 2015) whereby via apparently the same underlying mechanism 
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the removal of a protein’s activity from a cell can have widely divergent effects, 
depending upon the time course of that removal. 
 
Significance Statement 
Investigating enzyme function by genetic knock out is often complicated by indirect 
and compensatory changes, whilst supra-physiological levels of protein can 
compromise overexpression. These pitfalls have made it difficult to understand the 
functions of the enigmatic PI5P4Ks; we are even not sure what lipid phosphorylation 
they catalyse in vivo. Here we have employed the unique genetic power of DT40 cells 
to genomically delete PI5P4Kα or to remove the endogenous protein acutely (within 
60 minutes). We employed similar approaches to manipulate the endogenous catalytic 
activity of the enzyme. From this novel approach we have gained unique and 
unexpected insights into the physiological role of PI5P4Kα and the ways in which it 
interacts with the Akt signaling pathway. 
\body 
Introduction 
The phosphatidylinositol 5-phosphate 4-kinases (PI5P4Ks) are an enigmatic family of 
three (PI5P4Ks α, β and γ), whose cellular functions remain poorly understood (1-3). 
In general their principal activity is believed to be to remove, and thus regulate the 
levels of, their substrate phosphatidylinositol 5-phosphate (PI5P). Phenotypes from 
knock-out mice have highlighted that PI5P4Ks have important roles to play in 
physiology and pathology including links between PI5P4Ks and the Akt signaling 
pathway, and other studies have pointed to roles in the generation of cancer (3). A 
number of key questions, however, remain unanswered. Knocking proteins out or 
down (by RNAi) are long term strategies that may lead to indirect changes such as, 
for example, those highlighted in the recent study of Hart et al (4) concerning the 
indirect long term consequences of a point mutation in PI3Kα. Another issue still 
unresolved for PI5P4Ks is whether removal of PI5P is their only function, or whether 
their ability to synthesize phosphatidylinositol-(4,5)-bisphosphate (PI(4,5)P2) may 
also be important (5,6). 
We have recently used the high homologous recombination frequency of DT40 cells 
to tag endogenous PI5P4Ks and thus bypass the interpretational problems associated 
with cell transfection, and this has led to the demonstration of heterodimerization of α 
and β and a nuclear localization of endogenous PI5P4Kβ (7,8.9). DT40s, being of 
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avian origin, do not have a PI5P4Kγ gene, which facilitates the study of the functions 
and inter-relationship of the α and β isoforms (8). Here we have more fully exploited 
the genetic power of DT40s to gain unprecedented insight into the physiological 
functions of PI5P4Kα. 
 
Results 
Long term loss of PI5P4Kα  by gene disruption results in compromised Akt 
phosphorylation. 
Karyotype analysis of the DT40 cells with which we were working revealed trisomy 2 
(figure S1), the chromosome on which PIP4K2A resides. For three main reasons we 
chose to delete a 2.8kb segment of the gene encompassing exons 8 and 9: Firstly, with 
this short deletion we hoped to avoid off-target effects like those we saw in PIP4K2B-
/- cells (see supporting text and figures S2 and S3); secondly, these exons encode large 
portions of the PI5P- and ATP-binding sites of the kinase so any N-terminal fragment 
is unlikely to possess any function relying on ATP or PI5P binding; and thirdly, in 
cells with two of three alleles deleted we could mutate the catalytic activity of the 
third (below). PIP4K2A-/-/- cells have a similar growth rate to controls (figure S1) and 
unchanged PI5P4Kβ message (figure S4). Analysis of the phenotype of PIP4K2A-/-/- 
cells revealed a significant decrease in Akt phosphorylation at both Thr308 and 
Ser473 (human numbering) in both synchronized exponential growth and upon 
insulin stimulation (figure 1A,B). Given this consistency between assays we 
performed further experiments using the former protocol only. As an independent test 
of the phenotype of PIP4K2A-/-/- cells we knocked down PI5P4Kα by stable shRNA 
and found the same effect (figure S5). 
 
In order to see the Akt phenotype all three alleles of PIP4K2A had to be deleted. If we 
left one allele intact the Akt phosphorylation levels were indistinguishable from those 
in wild type cells. This gave us the chance to explore the mechanism behind this 
phenotype. Firstly, the remaining wild type allele was mutated to encode a kinase-
dead enzyme (D272K) (10). The allele was simultaneously tagged genomically at the 
C-terminus with EmGFP and as a control we knocked in an EmGFP tag alone to the 
third allele. The data show that whilst a remaining kinase-live third allele can support 
normal Akt phosphorylation, one that is kinase dead cannot (figure 1). Note that these 
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experiments are very tightly controlled as PIP4K2A-/-/kinase dead EmGFP cells and their 
controls (PIP4K2A-/-/EmGFP) differ by only one amino acid. 
 
To explore whether the function of PI5P4Kα here is to remove PI5P, generate 
PI(4,5)P2, or both, we used Kunz et al’s (11) finding that a single mutation (A381E) 
in the activation loop of human PI5P4Kβ changes its specificity from a PI5P 4-kinase 
to a PI4P 5-kinase. If PI5P removal is the main function of PI5P4Kα in the present 
context, such a mutation introduced into the non-deleted PIP4K2A allele should see 
the Akt phenotype emerge, but if PI(4,5)P2 synthesis is its function then, because 
there is plenty of PI4P present in most cellular membranes (1), the mutant should 
support normal Akt phosphorylation. First we tested directly using recombinant 
enzymes that the substrate specificity switch of human PI5P4Kβ (11) is valid in the 
chicken PI5P4Kα. The data (figure 1C) show that a marked (> 98%) substrate 
specificity switch occurs (note the logarithmic Y axis). Figure 1 shows that if the third 
PIP4K2A allele in PIP4K2A-/-/wt cells is mutated (A370E) to encode a PI4P 5-kinase 
normal Akt phosphorylation is maintained. Our interpretation of these experiments is 
that PI5P4Kα synthesizes a pool(s) of PI(4,5)P2 required for sustained 
phosphorylation of Akt. 
 
By generating PIP4K2B null cells we excluded a similar role for PI5P4Kβ in the 
regulation of Akt phosphorylation. Howver, complete deletion of PIP4K2B did result 
in indirect downregulation of PI5P4Kα (Fig S2). The consequent Akt phenotype was 
recued only by overexpression of PI5P4Kα, not of PI5P4Kβ, and then only if the 
PI5P4Kα was kinase live, irrespective of whether or not it was mutated to a PI4P 5-
kinase (see supplementary results and discussion and figures S2 and S3). 
 
PI5P4Kα is necessary for maintenance of normal plasma membrane PIP3 levels in 
DT40 cells 
Given that PI5P4Kα is a lipid kinase, the simplest explanation of decreased Akt 
phosphorylation is that PIP3 synthesis may be compromised (see Introduction). We 
therefore quantified PIP3 levels by mass spectrometry (12) in the cell lines shown in 
figure 1. A decrease in the mass of PIP3 was evident that followed the pattern of loss 
of Akt phosphorylation (figures 2 and S6), suggesting that at least part of this Akt 
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phenotype is due to decreased PIP3 synthesis. We confirmed these findings by 
overexpression of the fluorescent 3-phosphoinositde reporter EmGFP-PH-Akt (13) 
which was recruited less to the plasma mebrane in cells with deficient Akt 
phosphorylation (figure S3C). 
 
In light of these findings we wondered if the PI5P4Kα-generated PI(4,5)P2 was 
acting as a substrate for class 1 PI3-kinases to synthesise PIP3. Quantification of total 
PIP2 levels (which will be mostly PI(4,5)P2) in PIP4K2A-/-/- cells showed no change 
from wild-type (figure S6B), although this is not surprising given that the PI(4,5)P2 
required for PIP3 synthesis is a very small fraction of total cellular PI(4,5)P2. 
However, in cells where all the endogenous PI5P4Kα can be removed within an hour 
by the addition of auxin (below) no change in PIP3 levels upon acute removal of 
PI5P4Kα was detected, which would not be expected if PI5P4Kα-generated PI(4,5)P2 
acted as an immediate precursor for PIP3. The simplest interpretion of these data 
suggests that the PI(4,5)P2 pool generated by PI5P4Kα regulates PIP3 synthesis 
indirectly over a time course longer than a few hours rather than by acting as its lipid 
precursor, but the latter possibility cannot be ruled out with our current data. 
 
An auxin-inducible degradation system for PI5P4Kα reveals a contrasting 
phenotype of Akt phosphorylation 
As just discussed the simplest interpretation of the above data is that a pool of 
PI(4,5)P2 synthesized by PI5P4Kα is required for full PIP3 synthesis, but it is difficult 
to take this further in exploring what exactly is the primary defect using a knock-out 
strategy. However, the power of DT40 genetics also gave us a unique opportunity to 
try a completely different approach but now looking at the effect of acute removal of 
the PI5P4Kα protein. To do this we employed the auxin degron system, which has 
been used in a number of cells by transfection of degron-tagged protein, including 
DT40s (14). Here we tagged the PIP4K2A alleles directly with the auxin degron tag in 
a DT40 cell line that we had already stably transfected with the TIR1 protein (14) that 
is necessary for the auxin degron system to work. We also degron-tagged both alleles 
of PI5P4Kβ to make another cell line (PIP4K2Bdegron/degron), and this not only served 
as a control for any non-specific effects of the manipulations but also highlighted the 
specific role here of PI5P4Kα. 
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For PI5P4Kα, initially we generated a cell line where all three alleles of the gene were 
degron-tagged (PIP4K2Adegron/degron/degron). By trying various strategies we found that 
placing the degron tag at the C-terminus of the protein followed by a (His)6-FLAG tag 
(as in ref (8)) worked best in that: C-terminal tagging is easier than N-terminal 
tagging in this protocol, the tagged proteins could easily be quantified by 
immunoprecipitation and blotting, and the degron tag still worked effectively to target 
the protein for degradation. In both PIP4K2Adegron/degron/degron (figure 3) and 
PIP4K2Bdegron/degron (figure S7) cells addition of auxin led to the complete or near 
complete removal of the tagged protein within 60 minutes, a process that is reversible 
(figure S7). Blotting whole cell lysates with an anti-PI5P4Kα antibody shows that no 
wild type PI5P4Kα remains in PIP4K2Adegron/degron/degron cells (figure 3). The presence 
of the degron tag may reduce expression of PI5P4Kα slightly (figure 3) but we could 
detect no phenotypic difference in the cells. 
 
As we did not see the same changes in PIP3 mass levels upon acute PI5P4Kα removal 
compared to PIP4K2A deletion (see above) we felt it important to re-explore the Akt 
signaling phenotype in these new cells. As with the knockout cell lines we examined 
Akt phosphorylation under conditions of both insulin stimulation (figure 3C) and 
exponential growth in full medium (figures 3D and 4). Following an hour of serum 
starvation, cells not concurrently exposed to auxin exhibited insulin-induced Akt 
phosphorylation at both Thr308 and Ser473 as expected (15) in a dose dependent 
fashion (figure 3C). In cells depleted of PI5P4Kα the insulin-induced phosphorylation 
of Thr308 was unchanged or slightly increased, while the phosphorylation of Ser473 
was significantly enhanced (figure 3C). We saw the same effect of increased Ser473 
phosphorylation when cells were in exponential growth in full medium (figures 3D 
and 4A). This was confirmed to be a PI5P4Kα-specific effect as acute removal of 
PI5P4Kβ from PIP4K2Bdegron/degron cells had no effect on Akt phosphorylation (figure 
S8). We wondered whether the enhancement of Akt phosphorylation at Ser473 was 
stimulus-specific and therefore we treated our serum-starved  PIP4K2Adegron/degron/degron 
B-cells with the B-cell receptor agonist M4. Whilst, as expected (16) M4 treatment 
resulted in increased phospho-Akt, this effect was not enhanced by removal of 
PI5P4Kα (figure S9). There is therefore stimulus-selectivity in the regulation of Akt 
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Ser473 phosphorylation by PI5P4Kα. 
 
PI5P4Kα  is an acute negative regulator of mTORC2  
The above data suggest that acute loss of PI5P4Kα results in enhanced Ser473 
phosphorylation of Akt, with little or no effect on Thr308. As the kinase primarily 
responsible for Ser473 phosphorylation is mTORC2 (15) it seems most likely that 
PI5P4Kα is acting as a negative regulator of mTORC2 either directly or indirectly. To 
investigate this further we examined the phosphorylation states of the mTORC2 
targets SGK-1 and PKCα (15), and found phosphorylation of both to be increased 
upon acute removal of PI5P4Kα but not of PI5P4Kβ (figure 4). In contrast, and 
consistent with the lack of effect on Thr308 Akt phosphorylation (above), the 
phosphorylation state of the mTORC1 target p70S6K (15) is not affected by acute 
removal of PI5P4Kα (figure 4).  
 
An alternative explanation for these findings is that PI5P4Kα removal inhibits the 
phosphatase(s) responsible for dephosphorylating the three mTORC2 substrates. In 
order to address this we first confirmed that inhibition of TORC2 with the drug torin 
is successful in preventing phosphorylation of Akt at Ser473 in DT40 cells (figure 
S11A). We then attempted to assay the kinetics of dephosphorylation of Ser473-Akt 
and Ser422-SGK1 in PIP4K2Adegron/degron/degron cells with or without auxin induced 
removal of PI5P4Kα (figures S11B and S11C). Whether or not PI5P4Kα is depleted, 
complete dephosphorylation of the substrates examined occurs by the first time point 
at which we can reliably perform an assay (5 minutes). This rules out a fully 
quantitative experiment, but nevertheless these findings, coupled with the fact that 
different phosphatases are apparently responsible for removing the Ser473 phosphate 
of Akt and the Ser422 phosphate of SGK1 (17, 18), support PI5P4Kα being a 
negative regulator of mTORC2 as more likely than a positive regulator of two 
different phosphatases. 
 
Acute regulation of Akt by PI5P4Kα  depends upon PI(4,5)P2 generation 
The unexpected finding that the Akt signaling phenotype of PI5P4Kα-deficient cells 
is completely different depending upon the time course of PI5P4Kα removal begs the 
question whether the mechanism by which PI5P4Kα acts is the same in both cases; 
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that is: is kinase activity required in both cases, and if so is PI5P removal or PI(4,5)P2 
generation the primary effect? In order to address this question we employed a similar 
strategy to that described above for the stable knockout lines. Starting with 
PIP4K2Adegron/degron/wt cells we either mutated the third allele to be kinase dead or to 
have PI4P 5-kinase activity whilst simultaneously tagging this allele at the C-terminus 
with a (His)6-FLAG tag in both cases to generate PIP4K2Adegron/degron/kinase dead and 
PIP4K2Adegron/degron/substrate switch cells respectively. As a control we generated a cell line 
where we simply knocked a C-terminal (His)6-FLAG tag into the third allele 
(PIP4K2Adegron/degron/His-FLAG cells). This strategy allows degron-tagged but otherwise 
wild type PI5P4Kα to be acutely removed from the cell whilst leaving behind either 
kinase live, kinase dead, or substrate switched PI5P4Kα. Note that despite the likely 
homodimerization (8, 9) of PI5P4Kα monomers the non-degron tagged protein is not 
trafficked for degradation with its degron-tagged counterpart (figure 5), presumably 
because the kinetics of dimer dissociation are fast enough to prevent this.  
 
It should further be noted at this point that we were unable to achieve kinase dead and 
substrate switch mutations by the same strategies as previously: the single triplet 
changes required were repeatedly edited out, presumably by homologous 
recombination between alleles. We reasoned that more substantial coding changes 
might not be edited out, and found that if the kinase dead mutation was made by 
introducing a K366-368Q mutation into the activation loop, the equivalent of the 
K377-379Q substitution that Kunz et al (11) showed reduces the kinase activity of 
human PI5P4Kβ to less than 2% of wild type, the mutation was retained. The 
substrate switch was generated by the A370E (11) mutation as above, but in order to 
avoid repair by homologous recombination we had to introduce synonymous 
mutations into two neighboring triplets coding for K368 and A369. 
 
Addition of auxin to the PIP4K2Adegron/degron/kinase dead cells recapitulated the increase in 
Ser473 phosphorylation of Akt that was seen in PIP4K2Adegron/degron/degron cells (figure 
5), implying that the kinase activity of PI5P4Kα is required for it to fulfill this aspect 
of its function. Therefore the question again is whether PI5P removal or PI(4,5)P2 
generation is relevant; note that Jude et al (19) have reported that RNAi knockdown 
of PI5P4Kα leads to an increase in PI5P levels and mTOR activity. Adding auxin to 
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PIP4K2Adegron/degron/substrate switch cells and therefore leaving the cell with PI4P 5-kinase 
activity did not result in an increase in p-Ser473-Akt (figure 5) suggesting that 
generation of a PI(4,5)P2 pool by PI5P4Kα is crucial in this enzyme’s role as a 
negative regulator of mTORC2. 
 
Discussion 
A crucial result of our experiments is to establish for the first time that a functional 
pool (or pools) of PI(4,5)P2 is synthesized via a novel route; phosphorylation of PI5P 
rather than PI4P. For both the stable knockout and acute depletion of PI5P4Kα we 
established clear phenotypes to provide ‘read-outs’ of enzyme function and in both 
situations it was clear that the role of PI5P4Kα was to synthesize PI(4,5)P2 rather than 
to deplete PI5P. Of course in other settings PI5P depletion by PI5P4Kα may well be 
of physiological importance. Furthermore, the PI5P4Kα-generated PI(4,5)P2 has a 
regulatory influence over mTORC2 and PI3K-Akt signalling. 
 
It is striking, although perhaps not entirely unexpected, that very different phenotypes 
are identified upon chronic and acute depletion of PI5P4Kα. Given that in simple 
terms increased Akt phosphorylation is seen with acute PI5P4Kα removal and 
reduced Akt phosphorylation is seen chronically, it is tempting to speculate that the 
long-term phenotype is an adaptive consequence of the initial pertubation. As 
discussed in the Introduction, a profound change in cell physiology stemming from a 
single point mutation in Type I PI3Kα has been shown by Hart et al, which they 
called the ‘butterfly effect’ (4), and similar set of events may have taken place here. 
 
In other studies the impact of the PI5P4Ks on Akt signaling is not consistent between 
different organisms and different tissues using different techniques, and our 
demonstration of temporal variability may help to reconcile some of this data. For 
example stable knockout of Drosophila dPIP4K (orthologous to the high activity 
PIP4K2A in higher species) results in a dramatic attenuation of Akt phosphorylation 
(20), whilst acute depletion of PIP4K2A in human leukocytes by RNA interference 
results in increased Akt phosphorylation (19). No Akt phenotype was found in 
PIP4K2A knockout mice (21) but as far as we are aware cells of the haematopoietic 
lineage were not studied there; another study from the same group elegantly 
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demonstrated the tissue variability of gene knockouts, with PIP4K2B knockout mice 
having enhanced insulin-induced Akt phosphorylation in skeletal muscle and liver but 
not in white fat (22). Certainly it is not unreasonable to suggest a particular role of 
PI5P4Kα in blood cells given that these are the only cells reported so far to have an 
excess of this enzyme over the other isoforms (23). Our data from exploring a simple, 
single cell-type system highlight how difficult it can be to interpret primary protein 
function from knock-out phenotypes. More importantly, we suggest that the effects 
we see in the degron-tagged cells, a strategy which gives the cell no chance to adapt 
around changes caused by the removal of protein, may be revealing for the first time a 
primary and previously unsuspected cellular function of PI5P4Kα related to mTORC2 
regulation.  
 
At this stage it is unclear what mechanisms are leading to the different phenotypes, 
and clarification will take extensive further work. This is particularly so for the 
knock-out phenotype because of its indirect nature. For the acute phenotype it is 
interesting to note that the cellular location of endogenous PI5P4Kα in DT40s is 
largely cytoplasmic (figure S10), with all of it being attached to membranes (8), 
raising the possibility that it is localised to the endoplasmic reticulum, the same 
location in which mTORC2 has been reported to function (15). PI(4,5)P2 is at very 
low levels in intracellular membranes (1), so any synthesized here by PI5P4Kα could 
have a disproportionate impact. Indeed, synthesizing a localized pool of PI(4,5)P2 by 
a different metabolic pathway from most of the cell’s (PI4P5K-generated) PI(4,5)P2 is 
an attractive concept for controlling localised functions of this highly multi-functional 
(1) lipid. Note that if this is so, simplistically the PI(4,5)P2 pool made by PI5P4Kα 
that we have invoked here must have a negative effect on mTORC2 activity. 
(Superficially this might serve as the precursor for the PIP3 pool suggested recently by 
Liu et al in mTORC2 regulation (24), though as this appears to be stimulatory to 
mTORC2 the relationship of Liu et al’s observations with ours is unclear). There are 
two proteins reported as inhibiting mTORC2, DEPTOR (25) and XPLN (26), the 
latter being mTORC2-specific and thus potentially an endoplasmic reticulum protein, 
and both these proteins have the theoretical potential to bind PI(4,5)P2 via their PDZ 
or PH domains respectively; these considerations point to one way in which the 
negative infuence of PI5P4Kα on mTORC2 activity might be mediated. 
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Materials and methods 
All methodology pertinent to this study including cell line generation, signaling 
assays, and fluorescent and mass spectrometry based lipid assays can be found in 
supplementary materials and methods. 
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Figure Legends 
Figure 1 
The effect of endogenous PIP4K2A mutations on Akt phosphorylation at Thr308 and 
Ser473. 
 
A 
Cells were synchronized at the same density in exponential growth prior to analysis.  
Complete PIP4K2A deletion results in reduced phospho-Akt at both Thr308 and 
Ser473. Deletion of two of the three PIP4K2A alleles whilst leaving the third 
unaffected aside from tagging with EmGFP has no effect on Akt phosphorylation. 
This acts as a control for the fourth and fifth lanes where the undeleted allele is either 
rendered kinase dead or mutated to encode a PI4P 5-kinase (see materials and 
methods) along with EmGFP tagging in both cases. A kinase dead third allele does 
not support normal Akt phosphorylation in the way a kinase live one does, and it 
makes no difference to Akt phosphorylation whether the PI(4,5)P2 here is generated 
from PI5P or PI4P. Representative blot from three biological replicates. Note that 
these blots were captured electronically by a program that generates a negative image. 
In order to avoid any unnecessary image manipulation the original negative image is 
presented. 
 
B 
The cell lines shown in figure 1A were serum starved and insulin stimulated (see 
materials and methods). The pattern of deficient Akt phosphorylation was found to be 
the same as when cells were in exponential growth. 
 
C 
Substrate specificity of wild type PI5P4Kα and the A370E (substrate switched) 
mutant. Recombinant enzymes were assayed as described in the materials and 
methods section using either PI5P or PI4P substrates. Note the logarithmic y-axis. 
Wild type PI5P4Kα has two orders of magnitude less activity towards PI4P than 
towards PI5P whilst the A370E mutant prefers PI4P by almost three orders of 
magnitude. The activity of chicken PI5P4Kβ is included for comparison. The activity 
of chicken PI5P4Kα towards PI5P is about three orders of magnitude greater than that 
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of chicken PI5P4Kβ, very similar to the human enzymes (3). Quantification is of four 
technical replicates. 
 
 
 
Figure 2 
The effect of endogenous PIP4K2A mutations on PIP3 mass levels. Cells were 
synchronized at the same density in exponential growth prior to analysis by mass 
spectrometry. PIP3 levels are expressed relative to phosphatidylinositol (PI) to correct 
for cell number. PIP3 and PI internal standards are present in the assay. Data 
combined for 38:4, 38:3 and 36:2 PIP3 species. Chart displays means and 95% 
confidence intervals. 
Bonferroni’s multiple comparison test as follows: 
WT DT40 versus PIP4K2A-/-/-      P=0.065 
PIP4K2A-/-/EmGFP versus PIP4K2A-/-/kinase dead EmGFP    P<0.001 
PIP4K2A-/-/EmGFP versus PIP4K2A-/-/substrate switched EmGFP   P=0.97 
Pooled data from 3 replicates. 
The difference in PIP3 levels between WT and complete PIP4K2A knockout cells 
does not reach statistical significance despite the central estimate of PIP3 levels in the 
latter cell lines being 25% lower than in the former. This may be due to an inadequate 
number of replicates, so we also pooled data for the cell lines exhibiting normal Akt 
phosphorylation and compared these with pooled data for the cell lines exhibiting 
abnormal Akt phosphorylation (figure S6). 
 
Figure 3 
Acute removal of PI5P4Kα with the auxin degron system. 
 
A  
Cells (PIP4K2Adegron/degron/degron) were treated with auxin as indicated and any 
remaining PI5P4Kα-degron fusion protein was immunoprecipitated against its FLAG 
tag and blotted against its poly-His tag. 
 
B 
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Whole cell lysates blotted with an anti-PI5P4Kα antibody. 
 
C  
PIP4K2Adegron/degron/degron cells were serum starved with or without 500 micromolar 
auxin for 60 minutes to remove PI5P4K. Insulin was added at the concentrations 
shown and after 10 mins the cells were lysed and lysates blotted sequentially 
(stripping in between) for Akt phosphorylation at Thr-308 and Ser-473. 
 
D 
PIP4K2Adegron/degron/degron cells were synchronised in exponential growth and treated 
either with 500 micromolar auxin for 60 minutes to remove PI5P4Kα or with vehicle. 
The effect on Akt phosphorylation at Thr-308 and Ser-473 sites was examined. 
Quantitation of four such blots by densitometry is shown in the graph. Bars show 
mean and standard error. 
 
Figure 4 
The effect of acute removal of PI5P4Kα or PI5P4Kβ on mTORC1 and mTORC2 
phosphorylation targets. 
 
A 
Cells were synchronized at the same density in exponential growth before being 
treated for 60 minutes with 500 micromolar auxin and harvested for analysis. All 
blots use total cell free extract except those against the PI5P4K-degron fusion protein 
which are anti-poly-His blots of anti-FLAG immunoprecipitates as in figure 3A. 
 
B 
Quantification of the phosphorylation status of the mTORC2 substrates SGK-1 and 
PKCα in response to acute PI5P4Kα removal by densitometry measurements from 
three such blots as in figure 4A. Results normalized to the phosphorylation status of 
these substrates in the presence of PI5P4Kα. 
 
Figure 5 
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The requirement for PI5P4Kα to synthesize a pool of PI(4,5)P2 in order to regulate 
mTORC2 signalling. 
Cells were synchronized at the same density in exponential growth before being 
treated for 60 minutes with 500 micromolar auxin and harvested for analysis. 
As previously blots of Akt and phospho-Akt are on total cell lysates whilst blots of 
PI5P4Kα are anti-poly-His blots of anti-FLAG immunoprecipitates. 
 
A 
As previously, acute removal of PI5P4Kα from PIP4K2Adegron/degron/degron cells results 
in increased p-Ser473-Akt. In PIP4K2Adegron/degron/His-FLAG cells removal of the protein 
product from the two degron tagged alleles leaves the non degron-tagged protein 
present and this remaining protein is sufficient to support normal Akt 
phosphorylation. 
 
B  
When PIP4K2Adegron/degron/kinase dead cells are treated with auxin so as to leave the cells 
with only kinase dead PI5P4Kα an increase in p-Ser473-Akt results. PI5P4Kα 
therefore has to be kinase live in order to promote normal Akt phosphorylation. 
 
C 
By a similar strategy, treating PIP4K2Adegron/degron/substrate switch cells with auxin so the 
cells are left with PI5P4Kα that has been mutated into a PI4P 5-kinase has no effect 
on Akt phosphorylation. Therefore synthesis of PI(4,5)P2 rather than PI5P removal is 
the most likely function of PI5P4Kα here. 
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Supplementary Information 
 
Supplementary results and discussion 
DT40 cells exhibit trisomy 2 
Karyotype analysis of wild type DT40 cells by examination of DAPI stained 
metaphase spreads revealed trisomy for chromosome 2, the chromosome on which the 
PIP4K2A gene is located (figure S1). This is consistent with a previous karyotype 
analysis of DT40 cells (27) and means that three alleles have to be considered when 
designing experiments to endogenously manipulate the PI5P4Kα gene (see main 
manuscript). 
 
Initial observations pointing to a link between PI5P4Kα and Akt phosphorylation 
In addition to investigating the functions of PI5P4Kα we are also interested in 
elucidating the physiological roles of its isoenzyme PI5P4Kβ (encoded by the gene 
PIP4K2B). In light of this we generated PI5P4Kβ null cells (PIP4K2B-/-) by stable 
genomic deletion from the DT40 line, and surprisingly it was from these cells that we 
gained our first insight into the role of PI5P4Kα in the regulation of Akt. We noted 
that these cells had reduced Akt phosphorylation at both Thr308 and Ser473 (figure 
S3), but this was in the setting of off-target downregulation of PI5P4Kα (figure S2) 
and therefore it was unclear which isoform was responsible for the Akt phenotype. 
Note that we interpret this off-target downregulation of PI5P4Kα as an epigenetic 
consequence of loss of the PIP4K2B locus for two reasons: Firstly, long-range PCR 
and sequencing showed that the PIP4K2A loci were still intact in the PIP4K2B-/- cells; 
secondly, in these cells we had deleted the entire PIP4K2B locus including some of 
the 5’ untranslated region which is often responsible for epigenetic regulation (see 
supplementary material and methods); and thirdly, when we generated a PIP4K2B 
knockout in a less extreme way by introducing a stop codon into exon 1 and deleting 
exon 2 we saw no downregulation of PI5P4Kα. Whatever the details of this 
epigenetic mechanism these cells (PIP4K2B-/-) afforded us an initial opportunity to 
investigate the isoform responsible for the downregulation of Akt phosphorylation 
before proceeding to the formal PIP4K2A knockout we describe in the main body of 
the manuscript. 
 
We found that the deficit in Akt phosphorylation in PIP4K2B-/- cells was not rescued 
by stable overexpression of PI5P4Kβ, but was rescued by PI5P4Kα (figure S3). 
Importantly, overexpression of PI5P4Kβ in PIP4K2B-/- cells did not rescue the 
expression of PI5P4Kα from its suppressed levels (figure S2). Note also that our 
PIP4K2B null cells that did not show PI5P4Kα downregulation (see above) did not 
have an Akt phenotype. Consistent with our findings when endogenous PI5P4Kα was 
manipulated (see main results section), overexpressed PI5P4Kα could not rescue Akt 
phosphorylation in the present context when kinase dead, but remained able to do so 
when mutated to a PI4P 5-kinase (figure S3) suggesting that PI(4,5)P2 generation is 
the important function of PI5P4Kα here. As discussed in the main text we also used 
these cells for independent confirmation of our finding of reduced PIP3 levels in 
PIP4K2A-/-/- cells. We overexpressed the fluorescent 3-phosphoinositide reporter 
EmGFP-PH-Akt (see main manuscript) in PIP4K2B-/- cells and associated 
overexpression rescue lines and found a reduced plasma membrane to cytoplasm ratio 
of the PH domain of Akt following the pattern of loss of Akt phosphorylation (figure 
S3). 
 
Before proceeding to endogenous manipulations of PIP4K2A (see main manuscript) 
we also, at this point, sought evidence for the link between PI5P4Kα and Akt 
phosphorylation by creating cells in which PI5P4Kα was knocked down by stable 
shRNA (PIP4K2AshRNA). Figure S5 shows that these cells have 5.1% (95%CI 4.7% to 
5.5%) of wild type PIP4K2A message levels, but also an off target effect on PIP4K2B 
message which is at 39.6% (95%CI 37.7% to 41.4%) of wild type levels. These cells 
do have compromised Akt phosphorylation at both Thr308 and Ser473 (figure S5). 
We decided that it was not worth refining the knockdown experiment to limit off 
target effects on PI5P4Kβ as at this stage we had enough data to convince us to 
proceed directly to the definitive experiments of manipulating endogenous PIP4K2A 
(see main manuscript). 
 
How much PI5P4Kα is required to support normal Akt phosphorylation in stably 
manipulated cell lines? 
The fact that Akt phosphorylation is reduced secondary to stable PI5P4Kα loss in a 
number of cell lines that must contain varying amounts of PI5P4Kα raises the 
interesting question of whether we can say anything about the amount of PI5P4Kα 
required to maintain normal Akt phosphorylation. The short answer is that we cannot 
be precise because the signal on western blot from any antibody (whether to 
endogenous tags or native PI5P4Kα) on a whole cell lysate is too weak to be reliably 
quantifiable due to the low abundance of PI5P4Kα. Indeed we have to 
immunoprecipitate PI5P4Kα even to detect it by mass spectrometry (8), and reliable 
quantification to the precision required here following immunoprecipitation is 
difficult. There are some general conclusions we can draw, however, from the 
fluorescence signal given by endogenous PI5P4Kα EmGFP tags in our various cell 
lines. 
 
The situation in PIP4K2A-/-/- cells is straightforward; there is no functional PI5P4Kα 
protein and reduced Akt phosphorylation (figure 1). In PIP4K2AshRNA cells, which 
also have reduced Akt phosphorylation (figure S5), we have no way of assaying the 
PI5P4Kα that “leaks” through the knockdown but we can say that the encoding 
mRNA is at 5% of wild type levels (figure S5) and therefore the cells are likely to be 
severely crippled in terms of PI5P4Kα protein. Next we come to PIP4K2B-/- cells, 
which have compromised Akt phosphorylation secondary to off target down-
regulation of PI5P4Kα (figures S2 and S3). These cells have 50% of the wild type 
level of PI5P4Kα message, but in these cells we also have a way of reading out 
PI5P4Kα protein by endogenously tagging one PI5P4Kα allele with EmGFP to create 
PIP4K2AEmGFP/wt/wtPIP4K2B-/- cells. Figure S2 shows the confocal signal from these 
cells in comparison with PIP4K2AEmGFP/wt/wt cells where one allele of PIP4K2A is 
EmGFP tagged in a PIP4K2B wild type background. The confocal settings are the 
same in both sets of images in figure S2, and quantification of the background 
subtracted signal reveals that the mean fluorescence intensity in 
PIP4K2AEmGFP/wt/wtPIP4K2B-/- cells is 16% (95% CI 10% to 22%) of that in 
PIP4K2AEmGFP/wt/wt cells. Therefore our best estimate is that in PIP4K2B-/- cells 
PI5P4Kα protein is reduced by 84% despite PI5P4Kα message only being reduced by 
50%. This 84% reduction in protein is sufficient to result in compromised Akt 
phosphorylation. The final cell line that provides useful information here is PIP4K2A-
/-/EmGFP in which two alleles of PIP4K2A are deleted with the third being unaltered 
aside from having an endogenous EmGFP tag knocked in. These cells have normal 
Akt phosphorylation (figure 1), and figure S10B shows the EmGFP signal from these 
cells compared to PIP4K2AEmGFP/EmGFP/EmGFP cells in which all three PIP4K2A alleles 
are endogenously tagged with EmGFP. The background subtracted mean fluorescence 
intensity in PIP4K2A-/-/EmGFP cells is 68% (95% CI 61% to 75%) of that in 
PIP4K2AEmGFP/EmGFP/EmGFP. This suggests that some compensatory up-regulation of 
protein production from the undeleted allele in PIP4K2A-/-/EmGFP cells has occurred, 
and that 68% of wild type PI5P4Kα is sufficient to maintain normal Akt 
phosphorylation. We can therefore conclude, in round figures, that 70% of wild type 
PI5P4Kα can sustain normal Akt phosphorylation whilst 20% cannot, but we do not 
have data to establish more precisely the location of the “tipping point” between these 
two limits.  
 
Supplementary materials and methods 
DT40 tissue culture 
Basic culture medium for DT40 cells was formulated according to the protocol in 
(28). To 500ml of RPMI medium was added 50ml of FBS, 5ml of 200mM L-
glutamine, 5ml of chicken serum, and 120µl of 50mM 2-mercaptoethanol. Cells were 
cultured at 41°C in 5% CO2 and were typically kept at a density of between 2.5x105 
and 4x106 cells per ml of growth medium. 
 
Generation of targeting constructs for targeted transfection of DT40 cells 
Targeting constructs were built into an appropriate plasmid vector (typically 
pBluescript SK+ (Stratagene)). For gene deletions sequences of genomic DNA 
flanking the region to be deleted (targeting arms) were PCR amplified from DT40 
genomic DNA and ligated into the plasmid vector separated by an antibiotic 
resistance cassette to allow selection of drug-resistant clones. The targeting arms were 
typically 2kb in length. Following successful transfection and integration into the 
germline by homologous recombination the antibiotic resistance cassette replaced the 
region of the gene targeted for deletion. For integration of tags and mutations into the 
germline a similar strategy was employed, but in this case the targeting arms were 
manipulated such that successful recombination led to introduction of the new 
sequence of choice. See below for details of the generation of each targeting 
construct. 
 
Construct to endogenously tag PIP4K2A with EmGFP at the C-terminus 
The construct used to endogenously tag PIP4K2A with EmGFP at the C-terminus in 
DT40 cells was built into the multiple cloning site of pBluescript SK+ (Stratagene). 
Constructs used for genomic targeting never need to be expressed off their plasmid 
vector and so pBluescript, a bacterial cloning vector, is suitable for this purpose even 
though it will ultimately be transfected into eukaryotic cells. 
 
The 2kb 5’ homology arm of the PIP4K2A tagging construct was PCR amplified from 
DT40 gDNA using primers 2A5FOR2 and 2A5REV2 and cloned into pBluescript 
SK+ between KpnI and XbaI sites. An unwanted BamHI site was removed from the 
5’ arm by site directed mutagenesis using primers SDM5 and SDM6. Next the coding 
sequence for EmGFP was PCR amplified from the plasmid EmGFP-C1 (Clontech) 
(primers EGFP_PCR_FOR_1 and EGFP_PCR_REV_1) and cloned into the construct 
between XbaI and BamHI sites. The 2kb 3’ homology arm of the targeting construct 
was then cloned into the construct between BamHI and NotI sites following PCR 
amplification from DT40 gDNA (primers 2A3FOR2 and 2A3REV2). Finally either a 
puromycin resistance cassette or a blasticidin resistance cassette was ligated into the 
BamHI site of the construct. Having two constructs identical save for the antibiotic 
resistance conferred allowed sequential targeting of two PIP4K2A alleles using 
different selection antibiotics in order to derive the cell line PIP4K2Awt/EmGFP/EmGFP, 
which is resistant to both puromycin and blasticidin. Note that the antibiotic selection 
cassettes used contained their own eukaryotic promoters (29). The correct integration 
of each targeting construct was tested by long-range PCR and sequencing, and the 
presence of a third PIP4K2A allele was verified by the ability to PCR out a wild type 
region spanning the terminal PIP4K2A exon from PIP4K2Awt/EmGFP/EmGFP gDNA. In 
order to verify the correct expression of the PI5P4Kα– EmGFP fusion protein 
PIP4K2Awt/EmGFP/EmGFP cells were subjected to immunoprecipitation and western 
blotting with anti-GFP antibodies. A GFP-containing protein of the correct molecular 
weight was present in PIP4K2Awt/EmGFP/EmGFP cells but not in WT DT40 cells. 
Importantly this 70KDa protein was the only GFP-containing species present in the 
tagged cells. These controls to ensure accurate construct integration and appropriate 
fusion protein expression were performed for every tagged cell line generated. 
 
Constructs to delete PIP4K2A and PIP4K2B 
The 5’ arm of the PIP4K2A deletion construct was amplified from DT40 gDNA using 
primers GGPIP4K2A_DEL_5’_FOR_2 and GGPIP4K2A_DEL_5’_REV_2 whilst the 
3’ arm was amplified using primers GGPIP4K2A_DEL_3’_FOR and 
GGPIP4K2A_DEL_3’_REV. These arms were ligated into pBluescript SK+ between 
KpnI and BamHI sites (5’ arm) and BamHI and NotI sites (3’ arm). A neomycin, 
puromycin, or blasticidin resistance cassette was then ligated into the BamHI site to 
generate three constructs that were used sequentially in order to delete all three 
PIP4K2A loci to generate PIP4K2A-/-/- cells. 
 
The primer pairs used to amplify the 5’ and 3’ arms of the PIP4K2B deletion 
construct were 2b_Ful_Del_PCR_5’_For_1 and 2b_Ful_Del_PCR_5’_Rev_1, and 
2b_Ful_Del_PCR_3’_For_1 and 2b_Ful_Del_PCR_3’_Rev_1 respectively. The two 
PIP4K2B loci in DT40 cells were sequentially deleted using puromycin and 
blasticidin resistance cassettes to derive the cell line PIP4K2B-/-. 
 
Endogenous manipulation of the remaining wild type PIP4K2A allele in PIP4K2A-/-
/wt cells 
PIP4K2A-/-/wt cells, an intermediate on the way to generating PIP4K2A-/-/- cells, 
formed the starting point for three other cell lines used in this study. Firstly, the wild 
type allele was endogenously tagged with EmGFP using the targeting construct 
already described in order to generate PIP4K2A-/-/EmGFP cells. Secondly, the wild type 
allele was manipulated to render it both kinase dead (10) and EmGFP tagged 
(PIP4K2A-/-/kinase dead EmGFP cells). Thirdly, the final allele was manipulated to both 
confer it with PI4P 5-kinase activity instead of PI5P 4-kinase activity (11) and 
EmGFP tag it (PIP4K2A-/-/substrate switch EmGFP cells). In order to make the targeting 
constructs for the two latter cell lines the 5’ arm of the PIP4K2A EmGFP-tagging 
construct already described had to be extended in order to incorporate the region 
where the necessary mutations were to be inserted. A new 5’ arm was therefore 
generated for this construct using the primers 2a_Kin_Dead_PCR_For_2 and 
2A5REV2. After ligating this new 5’ arm into the construct the unwanted BamHI site 
again had to be removed by site-directed mutagenesis using the primers previously 
specified. This new construct was then subjected to another round of site-directed 
mutagenesis in order to introduce either the kinase-dead (10) mutation (D272K, 
primers 2a_Kin_Dead_SDM_F and 2a_Kin_Dead_SDM_R) or the substrate switch 
(11) mutation (A370E, primers 2alpha to type 1 SDM FOR and 2alpha to type 1 SDM 
REV). 
 
Constructs to overexpress PIP4K2A and PIP4K2B 
The full length coding sequences for chicken PI5P4Kα and β were not in genome 
databases at the time of this stage of the project so these were elucidated by 5’ RACE 
from DT40 mRNA. Generation of a full-length PIP4K2B cDNA for cloning was very 
difficult and therefore the overexpression construct for PI5P4Kβ was synthesized 
commercially (Invitrogen). A construct was made that encoded the PI5P4Kβ protein 
between HindIII and KpnI sites. The KpnI site then ran immediately into the coding 
sequence for a C-terminal FLAG-His6-His6 tag followed by a stop codon and a 
BamHI site. The construct was then ligated into pcDNA3.1 between HindIII and 
BamHI sites such that the expression of tagged PI5P4Kβ was driven off a CMV 
promoter with a properly established Kozak consensus sequence. 
 
Synthesis of a full-length cDNA for PIP4K2A was much easier and therefore we 
amplified the coding sequence from this using the primers GGPIP4K2A_OE_FOR 
and GGPIP4K2A_OE_REV. This coding sequence was then swapped into the 
PI5P4Kβ overexpression plasmid between HindIII and KpnI sites in order to allow 
the overexpression of PI5P4Kα appended to a C-terminal FLAG-His6-His6 tag. 
 
In order to derive plasmids to overexpress kinase dead and substrate switched 
PI5P4Kα the wild type overexpression construct was subjected to site directed 
mutagenesis using the primers already described. 
 
Construct to knock down PI5P4Kα by stable shRNA 
An shRNA sequence was designed against PI5P4Kα. A pair of oligonucleotides to 
encode this sequence (shRNA_PIP4K2a_FOR and shRNA_PIP4K2a_REV) were 
then annealed together and ligated into pSuper.neo (Oligoengine). This plasmid drives 
the expression of the RNA hairpin from an H1 promoter. 
 
Constructs to endogenously tag PIP4K2A and PIP4K2B with the auxin degron at 
the C-terminus 
The coding sequence for osTIR1 was PCR-amplified from the pNHK60 plasmid 
using the primers PCR-osTIR1-F and R and subcloned into pcDNA3.1 (Invitrogen) 
between Ecor1 and Kpn1 restriction sites. The DNA sequence encoding for an eight-
amino acid flexible linker followed by AtIAA17 tag (degron) were PCR-ampilfied 
from pNHK60 plasmid using the primers pBAIDII-1-F and R, and subcloned in-
frame with the C-terminal purification tag (a FLAG-(His6)2 tag) using a pBluescript 
SK+ derivative plasmid (21) to give rise to pBAIDII-1. The complete tag was then 
excised from pBAIDII-1 by digestion with Sal1 and BamH1 restriction 
endonucleases, gel-purified, and subcloned into pBAID2 (a pBluescript derivative 
containing the 3` homology arm to C-terminally tag PIP4K2B) to give rise to 
pBAIDII-2. The 5` homology arm to tag PIP4K2B was PCR-amplified from pBAID3 
using pBAIDII-3-F and R primers. The resulting DNA fragment was gel-purified, and 
ligated into pBAIDII-2 between Kpn1 and Sal1 restriction sites to give rise to 
pBAIDII-3. Selectable marker cassettes were cloned into pBAIDII-3 using the 
BamH1 site to give rise to pBAIDII-4 plasmid conferring blasticidin resistance and 
pBAIDII-5 plasmid conferring puromycin resistance. To create the targeting vector to 
C-terminally tag PIP4K2A with degron, the 5` and 3` homology arms to tag PIP4K2B 
in the pBAIDII-3 plasmid were replaced by the 5` and 3` homology arms to tag 
PIP4K2A, which were PCR-amplified from the construct designed to tag PIP4K2A 
with EmGFP at the C-terminus (described above) using the primers PCR-5`ARM-A-
AID-F/R and PCR-3`ARM-A-AID-F/R. The resulting plasmid was called pAAIDII-3. 
Finally, selectable marker cassettes were cloned into pAAIDII-3 using the BamH1 
site to generate pAAIDII-4 conferring blasticidin resistance and pAAIDII-5 
conferring puromycin resistance. 
 
Endogenous manipulation of the remaining wild type PIP4K2A allele in 
PIP4K2Adegron/degron/wt cells 
A new 5`arm had to be generated again as above but this time using the primers PCR-
Ext-5`ARM-IIa-F/R. The old 5`arm to tag PIP4K2A and the degron sequence were 
excised from pAAIDII-4 by Kpn1/Xba1 digestion, and the new 5`arm was then 
ligated into the resulting plasmid backbone so that to insert the new 5`arm in frame 
with a C-terminal FLAG-(His6)2 tag. This new construct (called pKDA4C) was then 
subjected to site-directed mutagenesis in order to introduce either the kinase-dead 
mutation (11) (K366-368Q, two rounds of SDM using the primers SDM-IIa-K366-
368-F/R-1 and SDM-IIa-K366-368-F/R-2 (the resulting plasmid was called 
pKDA4M2) or the substrate switch mutation (11) (A370E, two rounds of SDM using 
the primers SDM-IIa-A370E-F/R-1 (to introduce silent mutations into residues 368 
and 369, and the resulting plasmid was called pKDA4C2) and SDM-IIa-A370E-F/R-2 
(to introduce the point mutation A370E, which we called pKDA4T1). 
 
Generation of degron tagged DT40 cell lines 
PIP4K2Bdegron/wt cells were generated by transfection of pBAIDII-4 into the DT40 cell 
line stably expressing osTIR1. The resistance cassette was floxed out by transient 
transfection of Cre recombinase (as described below). The resulting cell line was then 
transfected with pBAIDII-5 to generate the PIP4K2Bdegron/degron cell line. 
PIP4K2Adegron/wt/wt cell line was generated by transfection of pAAIDII-4 into the 
DT40 cell line stably expressing osTIR1. The resistance cassette was floxed out as 
previously, and the resulting cell line was then transfected again with pAAIDII-4 to 
generate the PIP4K2Adegron/degron/wt cell line. Finally, pAAIDII-5 was transfected into 
the latter cell line to generate the PIP4K2Adegron/degron/degron cell line. 
 
The PIP4K2Adegron/degron/wt cell line was transfected separately with pKDA4C, 
pKDA4M2, and pKDAT1 plasmids to generate the cell lines PIP4K2Adegron/degron/His-
FLAG, PIP4K2Adegron/degron/kinase dead, and PIP4K2Adegron/degron/substrate switch respectively. 
 
Targeted transfection of DT40 cells 
Targeting constructs were linearized using an appropriate restriction enzyme, 
recovered by lithium chloride precipitation, and re-dissolved in PBS. DT40 cells in 
the logarithmic phase of growth were harvested and washed once in growth medium. 
1.5x107 cells were then resuspended and mixed with the DNA solution in an 
electroporation cuvette with a 4mm electrode gap (Biorad). The cells were then 
electroporated by discharging an exponentially decaying electrical pulse through them 
(600V, 25µF, Biorad Gene Pulser XCell). The cells were then immediately seeded out 
in 96 well plates. 24 hours later the appropriate selection antibiotic was added. Cells 
were incubated for seven days, by which time single drug-resistant colonies were 
visible. Colonies were picked from wells containing only one colony. After selection 
through antibiotic(s) gDNA was harvested in order to perform test PCR and 
sequencing reactions to check for correct construct integration. 
 
In order to control for off target effects and clonal variability all cell lines were 
independently derived three times (with the exception of PIP4K2A-/-/kinase dead EmGFP 
cells which were independently derived twice) and results confirmed in these 
independent clones. 
 
Stable non-targeted transfection of DT40 cells 
Stable non-targeted transfectants were generated and grown up from single cell clones 
in exactly the same way as targeted transfectants. Verification of correct expression 
was by western blotting and qPCR. 
 
Transient transfection of DT40 cells 
Transient transfection of DT40 cells was by electroporation using the same 
parameters as for targeted transfection described above. Following electroporation 
cells were seeded into growth medium and incubated overnight to allow time for 
expression from the transfected plasmid. Owing to the low transfection efficiency of 
DT40 cells transient transfection was only used where the transfected plasmid 
encoded a fluorochrome-tagged protein as this allowed successfully transfected cells 
to be identified by their fluorescence. 
 
Quantitative PCR 
RNA was harvested from DT40 cells using Trizol (Sigma) / chloroform / isopropanol 
extraction and used as a template for production of cDNA using Invitrogen 
SuperScript III primed from random hexamers. qPCR analysis was performed with a 
StepOne Plus qPCR machine and pre-designed TaqMan primer probe sets from 
Invitrogen. Gamma actin (ACTG) was used as the reference gene and the efficiency of 
all primer probe sets was determined by serial dilution. The Pfaffl method was used to 
calculate relative gene expression between cell lines and conditions in order to allow 
for correction of the differing amplification efficiencies of the primer probe set for 
each target gene. 
 
Immunoprecipitation of FLAG-(His)6-tagged proteins 
Protein extracts were pre-cleared by incubation with 30 μl of agarose beads for 30 
minutes at 4°C with gentle agitation. The agarose beads were pelleted by 
centrifugation at 13000 RPM for 1 minute using a Hettich Mikro 22-R bench-top 
centrifuge, and the supernatant was transferred into a new tube. IP of degron-tagged 
proteins was achieved by incubation of the pre-cleared protein extracts with 20μl of 
ANTI-FLAG® M2 Affinity Gel (Sigma) with constant rotation for 2 hours at 4°C. 
Beads were then pelleted by centrifugation at 13000 RPM for 30 seconds, washed 
three times in ice-cold PBS containing 0.1% triton X-100, and then twice in ice-cold 
PBS (with no detergent). Beads were finally mixed (1:1) with 2X SDS loading buffer 
and boiled for 5 minutes to elute proteins.  
 
Stimulation of DT40 cells 
DT40 cells in logarithmic growth were pelleted, washed twice in PBS, and incubated 
for one hour in RPMI with only 2% (v/v) FBS added. This served to serum starve the 
cells. Cells were then harvested, washed again, and resuspended in wash buffer 
containing either insulin from bovine pancreas (Sigma) at an appropriate 
concentration (see results), or mouse monoclonal M4 anti-chicken IgM antibody 
(Abcam) at a final concentration of 2μg/ml. Following stimulation cells were 
incubated for ten minutes prior to analysis. 
 
Western blotting 
Following denaturing SDS-PAGE electrophoresis of cell free extracts protein species 
were transferred onto an appropriate blotting membrane, which was probed with 
antibodies as detailed in supplementary materials and methods and detected using 
chemiluminescent reagents of an appropriate sensitivity. 
 
Lipid kinase assays 
These were performed exactly as previously described (30). 
 
Estimation of plasma membrane 3-phosphoinositdes 
DT40 cells were transiently transfected with the plasmid EGFP-PH-Akt, which 
encodes the PH domain of Akt fused to EGFP (13). In order to quantify recruitment 
of the PH domain of Akt to the plasma membrane the freely available software 
ImageJ (31) was used. Regions of interest were drawn both around the plasma 
membrane and in the cytosol and after background subtraction the mean pixel 
intensity in the plasma membrane and the cytosol was determined. The ratio of the 
two values was calculated to give a background corrected plasma membrane to 
cytoplasm ratio of the PH domain of Akt as a surrogate measurement of plasma 
membrane 3-phosphoinositides. The absolute value of this ratio is largely 
meaningless; the power of the technique lies in comparing the ratio between different 
DT40 cell lines. All cells were analysed blind to cell genotype. 
 
Confocal Microscopy 
Images were acquired with a Leica SP5 confocal microscope attached to a Leica 
DMI6000 inverted microscope stand. For GFP imaging excitation was with the 
488nm line of the argon laser and emission was detected between 500 and 550nm. For 
all imaging the confocal pinhole was set to 1 Airy unit, and an oil immersion 40x 1.25 
NA objective lens was used. All imaging was performed on live cells, which were 
embedded in Matrigel to prevent cell movement and transferred to uncoated glass 
bottom MatTek dishes. Just prior to imaging full growth medium was removed and 
replaced with RPMI without phenol red. Imaging was performed at 41°C under 5% 
CO2. 
 
Mass Spectrometry Quantification of lipids 
This was carried out exactly as in (26) using a QTRAP 4000 (AB Sciex) mass 
spectrometer and employing the lipid extraction and derivatization method described 
for cultured cells, with the modification that C17:0/C16:0 PtdIns(3,4,5)P3/PtdInsP2 
(10ng/ 0.175ng) and C17:0/C16:0 PtdIns (100ng) internal standards were added to 
primary extracts, and that final samples were dried in a Speedvac concentrator rather 
than under N2.  Measurements were conducted, in triplicate per experiment, on 
2x10e6 cells per sample. 
 
 
 
 
 
 
Primers 
Primer name Primer sequence (5’ to 3’)
2A5FOR2 TTA AGG TAC CGA GCT GCT GAG TGA TCC TAA AG
2A5REV2 GCA TTC TAG ACG TCA AGA TGT TGG CAA TAA AG
SDM5 CAA GTA GGG ACA CAT TGC ATC CAA CTG CAG TAG 
TTC AG 
SDM6 CTG AAC TAC TGC AGT TGG ATG CAA TGT GTC CCT 
ACT TG 
EGFP_PCR_FOR_1 TCT TCA TCT AGA ATG GTG AGC AAG GGC GAG GAG
EGFP_PCR_REV_1 CAC CAG GGA TCC TTA CTT GTA CAG CTC GTC CAT 
GC 
2A3FOR2 TAA TGG ATC CCC CCT CAT GTC ACA CCG GAC 
2A3REV2 TCA TGC GGC CGC TGC TAC ACA GAC AGA AAG TG 
GGPIP4K2A_DEL_5’_FOR_2 TGG TGG TAC CTA GTG GGA GGA CTT GCA AAT GAG 
G 
GGPIP4K2A_DEL_5’_REV_2 ACC AGG ATC CAA TCA GGT GTC AGA CCA CTT CAC 
G 
GGPIP4K2A_DEL_3’_FOR TAT AGG ATC CTC TGT GGG TAG TGT GCT TAG GTG
GGPIP4K2A_DEL_3’_REV ATT AGC GGC CGC CTG CCA GTC TGT CCA TCC TCT 
GA 
2b_Ful_Del_PCR_5’_For_1 TCA AGG TAC CTG GAG AGC AGA TTG TCA CAC 
2b_Ful_Del_PCR_5’_Rev_1 TGA CGG ATC CCA GAA AGA CAC ACA TAC ACA C 
2b_Ful_Del_PCR_3’_For_1 TGC AGG ATC CGC TTC CCT CGT GCT AAG GAT TG 
2b_Ful_Del_PCR_3’_Rev_1 TAA TGC GGC CGC GCT ACC TAC ATC CAG CAC AG 
2a_Kin_Dead_PCR_For_2 TAA TGG TAC CTT CCC ACT TAG TCC TCC GCT C 
2a_Kin_Dead_SDM_F CTC AGC TAA AAC TCA TGA AAT ACA GCT TGC TAG 
TTG G 
2a_Kin_Dead_SDM_R CCA ACT AGC AAG CTG TAT TTC ATG AGT TTT AGC 
TGA G 
2alpha to type 1 SDM FOR GAT GCA AAA AAG AAA GCT GAG CAT GCT GCA AAA 
ACA GT 
2alpha to type 1 SDM REV ACT GTT TTT GCA GCA TGC TCA GCT TTC TTT TTT 
GCA TC
GGPIP4K2a_OE_FOR TAA TAT AAG CTT GCT ATG GCG GCC CCC GGC ACC 
GTC 
GGPIP4K2a_OE_REV GAT AAT GGT ACC CGT CAA GAT GTT GGC AAT AAA 
GTC 
PCR-osTIR1-F ATA TGA ATT CAT GAC GTA CTT CCC GGA GGA G 
PCR-osTIR1-R ATA TGG TAC CTT ACC ACT AGC AGC AGA ACC GGA 
G 
pBAIDII-1-F ATA TGT CGA CGG AGC TGG TGC AGG CG 
pBAIDII-1-R ATA TTC TAG AAG CTC TGC TCT TGC ACT T 
pBAIDII-3-F ATA TGG TAC CGT GTG CAG TTT GTC TCA GTC C 
pBAIDII-3-R ATA TGT CGA CTG TCA GGA TAT TGG ACA TA 
PCR-5`ARM-A-AID-F ATA TGG TAC CGA GCT GCT GAG TGA 
PCR-5`ARM-A-AID-R AGT AGT CGA CCG TCA AGA TGT TGG 
PCR-3`ARM-A-AID-F ATA TGG ATC CCC CCT CAT GTC ACA
PCR-3`ARM-A-AID-R ATA TAT GCG GCC GCT GCT ACA C
PCR-Ext-5`ARM-IIa-F ATA TGG TAC CGA CCT GCA TGC TAT CAC TAC AT 
PCR-Ext-5`ARM-IIa-R ATG ATC TAG ACG TCA AGA TGT TGG 
SDM-IIa-K366-368Q-1-F ACT CAT TAT GAT GCA CAA CAG AAA GCT GC 
SDM-IIa-K366-368Q-1-R CAT GGG CAG CTT TCT GTT GTG CAT CAT AA 
SDM-IIa-K366-368Q-2-F ATG CAC AAC AAC AAG CTG CCC ATG CTG 
SDM-IIa-K366-368Q-2-R ATG GGC AGC TTG TTG TTG TGC ATC ATA A 
SDM-IIa-A370E-1-F GCA AAA AAG AAG GCC GCC CAT GCT GCA AA 
SDM-IIa-A370E-1-R GCA TGG GCG GCC TTC TTT TTT GCA TCA 
SDM-IIa-A370E-2-F GCA AAA AAG AAG GCC GAG CAT GCT GCA AA 
SDM-IIa-A370E-1-R GCA TGC TCG GCC TTC TTT TTT GCA TCA 
 
Antibodies 
Target Manufacturer and Product Number
Akt (total) Cell Signaling Technology #9272. 
Akt (phospho-Ser473) Cell Signaling Technology #4060. 
Akt (phospho-Thr308) Cell Signaling Technology #13038. 
Mouse IgG (H+L) peroxidase 
conjugated 
Vector Laboratories PI-2000. 
Rabbit IgG (H+L) peroxidase 
conjugated 
Abcam ab16284.
β-actin Sigma A2228.
6X His tag Abcam ab9108.
SGK-1 Abcam ab43606.
phospho-SGK-1 (Ser422) Santa Cruz Biotechnology SC16745R. 
PKCα BD Biosciences 610108.
phospho-PKCα (Ser657) Millipore 06822.
p70S6K Cell Signaling Technology (2708). 
phospho-p70S6K (Thr389) Cell Signaling Technology (9234). 
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Supplementary figure legends 
Figure S1 
A 
An example of a DAPI stained DT40 metaphase spread with the macrochromosomes 
and sex chromosomes identified and re-arranged. 
 
B 
Cells were seeded in full growth medium at a density of 2.5x105 viable cells per ml of 
and their growth observed over the next 48 hours without replenishing the medium. 
There is no significant difference in the growth rates of any of the cell lines. Means 
and 95% confidence intervals plotted. n=3 biological replicates. 
 
Figure S2 
PIP4K2B knockout cells exhibit off-target down-regulation of PI5P4Kα message and 
protein. 
 
A 
Quantification of PIP4K2A and PIP4K2B mRNA in PIP4K2B null cells (PIP4K2B-/-) 
and in these same cells when they are stably overexpressing PI5P4Kβ. Bars show 
mean and 95% confidence interval. The PIP4K2A mRNA in PIP4K2B-/- cells is 
reduced to 52% of wild type, 95%CI 47% to 57%. Overexpression of PI5P4Kβ in 
PIP4K2B-/- cells does not rescue PIP4K2A message (mean 53%, 95%CI 39% to 
68%). 
 
 
B 
The fluorescence signal from the PI5P4Kα-EmGFP fusion protein when one 
PIP4K2A allele is endogenously tagged with the EmGFP coding sequence in either a 
PIP4K2B wild type background or a PIP4K2B null background. 
 
Figure S3 
Compromised Akt phosphorylation in PIP4K2B-/- cells is due to off-target 
downregulation of PI5P4Kα. 
 
A 
The phosphorylation status of Akt at Thr308 and Ser473 in PIP4K2B null cells, and in 
the same cells when overexpressing either PI5P4Kβ or PI5P4Kα. 
 
B 
The phosphorylation status of Akt at Thr308 and Ser473 in PIP4K2B null cells, and in 
the same cells when overexpressing PI5P4Kα as in figure S3A. In addition the 
phosphorylation status of Akt is shown when the overexpressed PI5P4Kα is mutated 
to encode either a kinase dead enzyme or an enzyme with predominantly PI4P 5-
kinase activity (see materials and methods). 
 
C 
The plasma membrane to cytoplasm ratio of EmGFP-PH-Akt as a 3-phosphoinositide 
reporter in the cell lines shown in figure S3B. Bars show median and interquartile 
range. Pooled data from three biological replicates. 
Dunn’s multiple comparison tests as follows: 
DT40 WT versus PIP4K2B-/-       P<0.001 
PI5P4Kα rescue versus PIP4K2B-/-      P<0.001 
PI5P4Kαkinase dead rescue versus PIP4K2B-/-     P>0.05 
PI5P4Kαsubstrate switch rescue versus PIP4K2B-/-    P<0.001 
 
Figure S4 
Levels of PI5P4Kα and PI5P4Kβ mRNA in PIP4K2A null cells (PIP4K2A-/-/-) 
relative to wild type DT40 cells. Bar shows mean and 95% confidence interval. 
 
Figure S5 
Analysis of cells in which PI5P4Kα is knocked down by stable shRNA 
(PIP4K2AshRNA cells). 
 
A 
Levels of PI5P4Kα and PI5P4Kβ mRNA in PIP4K2AshRNA cells relative to wild type 
DT40 cells. Bars show mean and 95% confidence interval. n=3 biological replicates. 
 
B 
Phosphorylation status of Akt at Thr308 and Ser473 in PIP4K2AshRNA cells. Cells 
were synchronized in exponential growth prior to analysis. A sample from PIP4K2B-/- 
cells (see figure S3) is included for comparison. 
 
Figure S6 
Further mass spectrometry data from stable knockout cell lines. 
 
A 
PIP3 levels expressed relative to phosphatidylinositol (PI) to correct for cell number. 
PIP3 and PI internal standards present in assay. Data from the three cell lines that 
exhibit normal Akt phosphorylation in figure 2 are combined i.e. WT DT40, 
PIP4K2A-/-/EmGFP and PIP4K2A-/-/substrate switch EmGFP cells. Data from the two cell lines 
that exhibit deficient Akt phosphorylation in figure 1 are combined i.e. PIP4K2A-/-/- 
and PIP4K2A-/-/kinase dead EmGFP cells. Data is pooled for 38:4, 38:3 and 36:2 PIP3. Chart 
displays means and 95% confidence intervals. The central estimates show that PIP3 
levels in cells with deficient Akt phosphorylation are 65% of those in cells with 
normal Akt phosphorylation, P<0.0001, unpaired t-test. Pooled data from 3 replicates. 
 
B 
PIP2 levels expressed relative to PI to correct for cell number in PIP4K2A-/-/- cells. 
PIP2 and PI internal standards are present in the assay. 
 
Figure S7 
Test of the PI5P4Kβ-degron system. Blots of the PI5P4Kβ-degron fusion protein are 
anti-poly-His blots of anti-FLAG immunoprecipitates. 
 
A 
Endogenous auxin degron-tagged PI5P4Kβ can be acutely removed by auxin addition 
in a similar manner to degron-tagged PI5P4Kα (see figure 3). 
 
B 
When cells are washed and seeded into fresh growth medium the effects of auxin 
addition are reversible. 
 
Figure S8 
PI5P4Kβ was acutely removed from PIP4K2Bdegron/degron cells by treatment with 500 
micromolar auxin for the times shown. The phosphorylation status of Akt at Thr308 
and Ser473 was monitored. Cells were synchronized in exponential growth prior to 
analysis. 
 
Figure S9 
Stimulus specificity in the regulation of Akt phosphorylation by PI5P4Kα in 
PIP4K2Adegron/degron/degron cells. A representative blot comparing Akt phosphorylation 
at the Ser473 site in response to either insulin or M4 stimulation (see materials and 
methods) in the presence or absence of PI5P4Kα. Treatment with 500 micromolar 
auxin for one hour. The numbers below the blot are quantification of the p-Ser473-
Akt to total Akt ratio by densitometry. Results normalized to the ratio in serum-
starved cells. 
 
Figure S10 
Representative images from cells in which PI5P4Kα is endogenously tagged with 
EmGFP. 
 
A 
Paired brightfield and confocal images of endogenously tagged PI5P4Kα in 
PIP4K2AEmGFP/EmGFP/wt cells. 
 
B 
Confocal images of the EmGFP signal from PIP4K2AEmGFP/EmGFP/EmGFP cells and 
PIP4K2A-/-/EmGFP cells. The same illumination and detection settings are used in each 
case. 
 
Figure S11 
The effect of TOR inhibition on the phosphorylation status of mTORC2 targets. 
 
A 
The extent of dephosphorylation of Akt at Ser473 upon treatment of exponentially 
growing DT40 cells with various concentrations the TORC2 inhibitor torin for 60 
minutes. DMSO is the vehicle for torin. 
 
B 
Exponentially growing PIP4K2Adegron/degron/degron cells were treated with either auxin 
or vehicle for 60 minutes, and then the rate of dephosphorylation of Akt at Ser473 
was assayed upon inhibiton of TORC2 with torin. 
 
C 
Exponentially growing PIP4K2Adegron/degron/degron cells were treated with either auxin 
or vehicle for 60 minutes, and then the rate of dephosphorylation of SGK1 at Ser422 
was assayed upon inhibiton of TORC2 with torin. 
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Torin 250nM 
Vehicle 
SO 5 mins 10 mins 
Torin 250nM 
Auxin 
Phospho-Ser473-Akt 
Total Akt 
B 
Phospho-Ser422-SGK1 
Total SGK1 
D
M
SO
 
5 
m
in
s 
10
 m
in
s 
Torin 250nM 
Vehicle 
Torin 250nM 
Auxin 
15
 m
in
s 
20
 m
in
s 
D
M
SO
 
5 
m
in
s 
10
 m
in
s 
15
 m
in
s 
20
 m
in
s 
C 
